Call Options Transactions Made in Q3 2024 in Rocket Pharmaceuticals, Inc. (RCKT)
This table provides information about the institutional ownership of Rocket Pharmaceuticals, Inc. (RCKT) during Q3 2024. The information is specifically focused on institutions that hold call options of ROCKET PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2024
Q3 2024
|
Jefferies Financial Group Inc.
New York, NY |
BUY
|
CALL |
46.9KNew |
$825K - $1.21M
|
46.9K
$552K
|
|
|
Nov 14, 2024
Q3 2024
|
Caption Management, LLC
Oklahoma City, OK |
BUY
|
CALL |
40K+ 66.67% |
$704K - $1.04M
|
100K
$1.18M
|
|
|
Nov 15, 2024
Q3 2024
|
Barclays PLC
London, X0 |
BUY
|
CALL |
30KNew |
$528K - $776K
|
30K
$353K
|
|
|
Nov 14, 2024
Q3 2024
|
Jane Street Group, LLC
New York, NY |
BUY
|
CALL |
10.9KNew |
$192K - $282K
|
10.9K
$128K
|
|
|
Nov 14, 2024
Q3 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
2.7K+ 13.3% |
$47.5K - $69.9K
|
23K
$270K
|